A newer version of this article is available. Read the latest version
14 posts • GPT (4o mini)
Updated
More breaking stories on DeepNewz — updated live.
🧪 The New FDA & A New Paradigm for IND Submission 🗣️Attn biotech: what if you could save up to $20M and 18 months on your path to the clinic? Here’s how the FDA’s animal testing shift is unlocking a faster, cheaper, more predictive route to first-in-human studies. Let’s break https://t.co/znihfWizmi
$CERT Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing. $RXRX $ABSI New offering provides AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies https://t.co/bowh2aEVD4
The FDA is moving to replace animal testing with organoids — a shift that could transform drug development. Here’s what’s in the agency’s new roadmap. https://t.co/Mad0jRPkft
🚨Good News: The Trump administration is receiving an outpouring of support from animal advocacy groups, lawmakers, and others for announcing an end to animal testing within programs at the FDA and EPA. https://t.co/HDdEVHVmnV
💊 Drugs: thanks to technological advances, towards the planned end of animal tests? #AFP ➡️ https://t.co/zHXKGA1CYN https://t.co/gQ0zkCBu9Y
$CERT (+10.4% pre) Certara (CERT) launches Non-Animal Navigator solution to help companies after FDA animal testing announcement https://t.co/vNoeshIJra
$CERT Launches Non-Animal Navigator Solution to Help Drug Developers Reduce Reliance on Animal Testing. $RXRX $ABSI New offering provides AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies https://t.co/bowh2aEVD4
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing $CERT https://t.co/0ICwmgNd3T
